A cytotoxicity assay further demonstrated the capacity of the PD1-Syn-IL-12-NK92 cells to augment the cytolytic activity of CAR-NK cells against PDL1-positive breast cancer target cells (Figure 6). This evidence concerns the gene CD274 and breast cancer.